Mēdota
Recruiting clinical trials for any condition, with a recruiting site in your country, explained in plain language and linked to the official registers.
- Brand
- Mēdota
- Category
- Health & Wellness
- Primary Subcategory
- Biomedical & Pharma Research Intelligence
Integration details
Description
Mēdota shows patients and families which clinical trials are recruiting for a condition in their own country, and explains them in plain language. Claude answers in the language you write in. What it covers - Trials from ClinicalTrials.gov, the EU Clinical Trials Information System (CTIS) and the German Clinical Trials Register (DRKS, run by BfArM), refreshed every night. - A trial is listed for a country only when it is recruiting and at least one of its sites in that country is recruiting. - A trial listed in more than one register appears once when Mēdota can confirm it is the same trial, with links to each register. If that cannot be confirmed, both entries stay. - Every trial carries a link to its official record, the date its sponsor last updated that record and the date Mēdota last checked it. Trials whose recruiting status may be out of date are marked and listed last. - Plain-language explanations are written by AI from the register's public text and checked against it. Where a check fails, and for German register records from before 2025, Mēdota shows the title and a link only. - Ask what is new since a date to see trials that opened, changed status or added a site. What it does not do Mēdota describes trials studying a condition. It does not judge whether you or a family member can take part, and it gives no medical advice. Whether a trial fits is decided by the trial team together with your doctor. Privacy No account and no sign-in. Mēdota receives only the condition, the country, a trial number or a date from your question. It keeps no record of questions, no conversation text and no IP addresses, only monthly totals of how often each condition and country is asked about. The service runs on servers in Germany. Built by a father whose son has a rare disease and whose father has Alzheimer's, for patients and families living with complex illness.
- Integration type
- Connector
- Verification status
Community connector- Platform
- Claude
- Primary Subcategory
- Biomedical & Pharma Research Intelligence
- Secondary Subcategories
- None listed
- Brand
- Mēdota
- Access
- No account required
- First tracked
- 2026-10-24
- Tool count
- 3
- Geography
- US
The Primary Subcategory used for this profile’s headline score.
Other Subcategories where the Integration is listed.
Claude Connector discovery is coming soon
Community Connectors only appear in Claude’s registry.Once verified, organic discovery begins and we can calculate your score.Read more about Community Connector verification.
No spam. Unsubscribe any time.
What discovery looks like

Claude can surface verified Connectors when they match a user’s Prompt.
How Claude Connector discovery works
Your Connector will compete to appear for users’ Prompts once Claude verifies it
Competing in Claude Biomedical & Pharma Research Intelligence
View Category3 tools agents can invoke
Mēdota Claude Connector FAQ
How the directory, categories and Discoverability Score work.
Read the methodologyHow do I improve Mēdota's Claude Connector discoverability?
The levers are the listing surface agents actually read: names, descriptions, keywords, tool metadata, and registry health. Which lever matters depends on where discovery breaks, which is what continuous measurement shows.
What are Mēdota alternatives on Claude?
As of 2026-10-25, Mēdota competes with Clinical Trials, AdisInsight, AgingResearch.News, Amass Connector, Boltz API, BPIQ, Convoke, Cortellis CMC Intelligence and 20 more in Claude Biomedical & Pharma Research Intelligence, ranked by public Discoverability Score.
Where is this profile measured?
This profile uses the geography attached to the latest public registry snapshot: US. Locale tags are intentionally omitted.